quinazolines has been researched along with fluconazole in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 9 (69.23) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Cuenca-Estrella, M; Monzón, A; Ramos, G; Rodríguez-Tudela, JL | 1 |
del Palacio, A; Garau, M; Pereiro, M | 1 |
Bartroli, J; Benjamin, DK; Boyce, M; Miller, JL; Perfect, JR; Schell, WA; Toffaletti, DL; Wills, EA | 1 |
Cho, A; Dudley, MN; Glinka, TW; Iqbal, N; Lemoine, RC; Lolans, K; Lomovskaya, O; Madsen, D; Oza, U; Singh, R; Watkins, WJ; Yang, J | 1 |
Barnard, J; Cho, A; Chong, L; Dudley, MN; Garizi, N; Iqbal, N; Jankowska, R; Kuo, B; Lemoine, RC; Lolans, K; Lomovskaya, O; Ludwikow, M; Madsen, D; Oza, U; Renau, TE; Singh, R; Watkins, WJ; Wong, V | 1 |
Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
Alves, SH; Azevedo, AC; Boff, E; Da Matta, DA; Guarro, J; Loreto, ES; Santurio, JM | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Arechavala, AI; Bianchi, MH; Negroni, R; Robles, AM; Santiso, G | 1 |
Elizondo, M; Garza-González, E; González, GM; González, JG; Robledo, E | 1 |
Im, HA; Kim, A; Kim, JY; Kim, YH; Ryu, CK; Yoon, JH | 1 |
Adedoyin, A; Fancourt, C; Iwamoto, M; McCrea, JB; Menzel, K; Panebianco, D; Stoch, SA; Tomek, C; Zhao, T | 1 |
Aoki, J; Fukuda, T; Furukawa, T; Hashimoto, H; Inamoto, Y; Ito, A; Kim, SW; Nakashima, T; Tanaka, T | 1 |
1 trial(s) available for quinazolines and fluconazole
Article | Year |
---|---|
Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants.
Topics: Acetates; Adult; Antifungal Agents; Antiviral Agents; Area Under Curve; Drug Interactions; Female; Fluconazole; Humans; Middle Aged; Quinazolines; Young Adult | 2021 |
12 other study(ies) available for quinazolines and fluconazole
Article | Year |
---|---|
In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Quinazolines; Triazoles | 1999 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Fluconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Quinazolines; Rabbits; Survival Analysis; Triazoles | 2004 |
Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Fungal Proteins; Humans; In Vitro Techniques; Membrane Transport Modulators; Membrane Transport Proteins; Models, Molecular; Piperazines; Quinazolines; Solubility; Stereoisomerism; Structure-Activity Relationship | 2004 |
Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivatives.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Fungal Proteins; Humans; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Piperazines; Quinazolines; Stereoisomerism; Structure-Activity Relationship | 2004 |
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole | 2005 |
In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Quinazolines; Thiazoles; Triazoles | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
[Identification and susceptibility against fluconazole and albaconazole of 100 yeasts' strains isolated from vaginal discharge].
Topics: Adult; Antifungal Agents; Body Fluids; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Middle Aged; Quinazolines; Triazoles; Trichosporon; Vagina | 2007 |
Efficacy of albaconazole against Candida albicans in a vaginitis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Female; Fluconazole; Mice; Mice, Inbred BALB C; Quinazolines; Triazoles; Vaginitis | 2009 |
Synthesis and antifungal activity of 6,7-bis(arylthio)-quinazoline-5,8-diones and furo[2,3-f]quinazolin-5-ols.
Topics: Antifungal Agents; Aspergillus; Candida; Chemistry, Pharmaceutical; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Microbial Sensitivity Tests; Models, Chemical; Quinazolines; Structure-Activity Relationship; Sulfhydryl Compounds | 2012 |
Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal.
Topics: Acetates; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Quinazolines; Tacrolimus; Voriconazole | 2022 |